It’s understood that around 6,000 patients could benefit from this.
The Irish Patients Association today welcomes the agreement reached between the State and the Irish Pharmaceutical Healthcare Association for a four-year medicines deal, expected to be approved by the Government.
According to Chair of the Irish Patients Association, Stephen McMahon said "This agreement addresses an unconscionable two-tier system where private patients access new cancer treatments up to two years before public patients can access the same medicine through the HSE."
For cancer medicines, it would cut delays by 514 days from the current 694-day average.
The agreement appropriately balances patients' rights to equitable access and innovation with the State's responsibility to ensure cost-effectiveness within finite health budgets.
Approximately 32 new medicines are expected this year, covering treatments for cancer, diabetes, and heart disease.
It’s understood that around 6,000 patients could benefit from this.
Kfm Obituary Notices
Over Half of Cigarette Packs Surveyed In Newbridge And Naas Had No Irish Duty Paid
Celbridge Brewery CEO Warns Of Mounting Costs Facing Craft Beer Sector
Radio is One of Ireland’s Biggest Daily Habits as 3.5 Million Tune In Every Weekday
Appeal For Dashcam Footage After Waste Dumped And Set Alight In Kilteel Area
Amhrán na Laoch Songwriting Competition Confirmed for Irish Music Month 2026
Gardaí Appeal For Information After €300 Perfume Theft In Leixlip
